Ataga, Kenneth I <br/><br/>
Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemia.  [electronic resource] 

 -  Blood  Apr 2008 
 - 3991-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2007-08-110098  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--adverse effects<br/>Adolescent<br/>Adult<br/>Anemia, Sickle Cell--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Potassium Channel Blockers--adverse effects<br/>Time Factors<br/>Treatment Outcome<br/>Trityl Compounds--adverse effects